Artificial intelligence-based disease detection technology company Viz.ai announced today that it raised $100 million in a Series D financing round. San Francisco-based Viz.ai develops AI algorithms that detect disease and offer hospital systems a way to ensure that, once detected, the patients are captured, and workflows across an entire health system are standardized. The latest […]
Viz.ai
FDA clears AI algorithm from Viz.ai for detecting cerebral aneurysms
Viz.ai announced today that it received FDA 510(k) clearance for its Viz Aneurysm algorithm for detecting suspected cerebral aneurysms. San Francisco-based Viz.ai’s new algorithm uses artificial intelligence (AI) to detect the aneurysms, offering hospital systems a way to ensure that, once detected, the patients are captured and the aneurysm workflow across an entire health system […]
Viz.ai launches AI-powered modules for pulmonary embolism, aortic disease
Viz.ai announced today that it launched its artificial intelligence-based modules for managing pulmonary embolism and aortic disease. San Francisco-based Viz.ai said in a news release that the new modules allow for faster clinical decision making and improved care coordination for patients with the two life-threatening conditions. The company is debuting the modules at the 48th […]
Viz.ai wins CE mark for AI-powered stroke care software
Viz.ai announced today that it received CE mark approval for its flagship Viz LVO AI-based stroke care software platform. San Francisco–based Viz.ai developed Viz LVO to use AI to automatically detect suspected large vessel occlusion (LVO) strokes on computed tomography angiography (CTA) imaging. Once the platform detects stroke, it directly alerts on-call stroke specialists about […]
MedTech 100 roundup: Small dip keeps industry down
The last month brought a bit of a skid for the medtech industry and after a slight rebound last week, the downward trend has returned. A strong start to 2021 came to an end in late February and carried over into March, with MassDevice‘s MedTech 100 index hitting its lowest point on March 8 (102.16). It […]
Viz.ai raises $71 million Series C, touts positive data for stroke care outcomes
Artificial intelligence platform developer Viz.ai announced that it raised $71 million in a Series C financing round. San Francisco-based Viz.ai develops AI software for treating acute ischemic stroke. The software uses a computer-aided triage system to identify a suspected large-vessel occlusion via CT scan and alerts a stroke team specialist to reduce the time to […]
Viz.ai stroke software lands Medicare ‘new technology’ coverage
The Centers for Medicare and Medicaid Services (CMS) has granted Viz.ai the first New Technology Add-on Payment (NTAP) for artificial intelligence software, the company announced today. NTAP, part of the CMS inpatient prospective payment system, was set up to support the adoption of cutting-edge technologies that have demonstrated substantial clinical improvement and ensure early availability to Medicare […]
Viz.ai lands $50m Series B for stroke treatment
Viz.ai said yesterday that it received $50 million in Series B funding for its artificial intelligence software for treating acute ischemic stroke. The San Francisco-based company uses a computer-aided triage system designed to identify a suspected large vessel occlusion via CT scan and alerts a stroke team specialist within minutes, reducing the time to treatment […]
Medtronic inks deal for Viz.ai’s stroke tech
Medtronic (NYSE:MDT) said today that it inked a deal to distribute the stroke-detection software developed by Viz.ai. San Francisco-based Viz.ai’s LVO Stroke platform is designed to analyze computed tomography results and notify providers of potential strokes. The technology won 510(k) clearance from the FDA in February 2018. The deal with Fridley, Minn.-based Medtronic calls for […]
Google joins $21m Series A for Viz.ai
Artificial Intelligence healthcare developer Viz.ai has raised $21 million in a Series A funding round joined by GV, formerly known as Google Ventures. The round was led by Kleiner Perkins, the San Francisco-based company said. In connection with the funding round, Kleiner Perkins general partner Mamoon Hamid will join the company’s board of directors. “We were attracted […]
Viz.ai wins FDA nod automated CT perfusion software
Artificial Intelligence healthcare developer Viz.ai said yesterday it won FDA 510(k) clearance for its Viz CTP computed tomography perfusion image processing and analysis software. The San Francisco-based company said that the software compliments its current offerings, which include automated large vessel occlusion stroke identification, stroke triage and LVO notification, patient selection, medical image viewing, transport coordination and […]
